One Type of Older Diabetes Drug Cuts Dementia Risk, Another Ups It

Observational study data suggest thiazolidinediones may be protective when it comes to dementia risk in patients with type 2 diabetes, whereas sulfonylureas increase the risk, compared with metformin.

Related Keywords

Arizona ,United States ,United Kingdom ,James Connell ,Xin Tang ,Thiazolidinediones Tzds ,Ivan Koychev ,University Of Arizona Mel ,National Institute Of Diabetes ,University Of Oxford ,National Science Foundation ,United Kingdom Science Media Centre ,Diabetes Research Care ,Alzheimer Research United Kingdom ,National Human Genome Research Institute ,Blood Institute ,National Heart ,Oxford University ,Enid Zuckerman College Of Public Health ,Us Veterans Affairs Administration ,Novo Nordisk ,Affairs Administration ,Diabetes Research ,Trials Needed ,Determine Cause ,Research United Kingdom ,United Kingdom Science Media ,Versus Metformin ,Uarizona Mel ,Enid Zuckerman College ,Public Health ,More Pronounced ,Those With Obesity ,National Institute ,Kidney Disease ,Diabetes Mellitus Type 2 ,Iabetes Mellitus Type Ii ,Type 2 Diabetes ,Diabetes ,Diabetes Mellitus ,United Kingdom Site Content ,Dementia ,Alzheimers Disease ,Lzheimer Disease ,Sulfonylureas ,Obesity ,Bese ,Endocrinology ,Ndocrine System ,Body Mass Index Bmi ,